Skin Cancer
- Chronic irAEs Common After Anti-PD-1 Therapy in Patients With High-Risk Resected Melanoma
- CDKN2A Mutation and Higher Nevus Count Can Increase Risk for Subsequent Primary Melanoma
- In Situ, Invasive Melanoma Diagnoses Decreased in 2020
- Global Incidence of Early-Onset Cancers Rose 80% From 1990 to 2019
- Patients With Cancer and ICI-Induced Acute Pancreatitis May Require Imaging, Monitoring
- High-Risk Patients With Melanoma More Likely to Receive Immunotherapy at End of Life
- Hydrochlorothiazide vs ACE Inhibitors: No Clear Difference in Skin Cancer Risk
- Hashimoto Thyroiditis: Nonsignificant Risk Factor in Melanoma, Other Skin Cancer
- Percentage of Women Mohs Fellows, Program Directors Has Increased
- T-VEC Demonstrates Long-Term Efficacy in High-Risk Melanoma
- Lorazepam Use Linked to Shorter PFS, OS in Several Cancers
- Nivolumab-Ipilimumab Increases Treatment-Free Survival in Advanced Melanoma
Clinical Tools
Powered by
Powered by 
